New cream and app aim to ease radiation burns for cancer patients

NCT ID NCT06441266

Completed Symptom relief Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 07, 2026 · Updated 5 times

Summary

This pilot study tests whether a special cream (KeraStat) and a mobile app (MyCap) can help manage skin rashes caused by radiation therapy in head and neck cancer patients. Sixteen participants will apply the cream at least twice daily during radiation and use the app to report their symptoms. The main goal is to see if this approach is practical for a larger future study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: KeraStat cream (a protective emollient-based wound dressing applied topically)
What this could lead to: If successful, this approach could make it easier for patients to track and manage radiation skin rashes from home, improving comfort and reducing clinic visits.
What could go wrong: This is a very small pilot study (16 people) focused on feasibility, not on proving the cream works. The results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer radiodermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RADIATION DERMATITIS

Contacts and locations

Locations

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.